ABCG2 and cancer: It has a broad substrate spectrum and can transport various anticancer drugs, including SN-38, methotrexate, topotecan, and imatinib, which means that overexpression of ABCG2 by cancer cells causes multidrug resistance [1,2,3,4,5].